FN1 and lung carcinoma: It has been earlier shown that the adhesion of lung carcinoma cells to fibronectin reduces apoptosis induced by standard chemotherapeutic agents and enhances tumorigenicity [22], which supports the hypothesis that fibronectin could have value as a therapeutic target in cancers [23].